Nicotinamide Adenine Dinucleotide 1g & Retatrutide - A UK Report
The recent landscape of metabolic wellness in the UK is seeing heightened interest in the synergy of high-dose Nicotinamide Adenine Dinucleotide supplementation – often at 1g dosage – and the novel GLP-1 receptor agonist Retatrutide (or its similar Tirzepatide). Researchers are observing potentia